id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,chunk_num_tokens,output,is_chunked
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 7
comparator:
  mean: 252.37
  standard_deviation: 11.29
  group_size: 8",False
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,-0.1554,0.2508,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 10.2±1.3
  standard_deviation: 1.3
  group_size: 16
comparator:
  mean: 2.5±0.6
  standard_deviation: 0.6
  group_size: 1",False
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,0.3277,0.0687,,,,,Values are for week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 1.16
  standard_deviation: 0.42
  group_size: 30
comparator:
  mean: 1.11
  standard_deviation: 0.23
  group_size: 29",False
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],"intervention:
  mean: 0.46
  standard_deviation: 0.03
  group_size: 30
comparator:
  mean: 0.43
  standard_deviation: 0.04
  group_size: 30

Please note",False
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,0.2624,0.0908,,,,,found in table,TRUE,4402,2905,TEST,2274,[],"intervention:
  meaning: ""GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)""
  group_size: 20
  mean: 0.72 ± 0.",False
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,0.1225,0.0954,,,,,,TRUE,1345,1148,TEST,971,[],"intervention:
  mean: 34.57
  standard_deviation: 14.64
  group_size: 21
comparator:
  mean: 32.76
  standard_deviation: 14.34
  group_size: 21",False
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: 8.1
  standard_deviation: 10.5
  group_size: 122
comparator:
  mean: 0.0
  standard_deviation: 0.0
  group_size: 122

Note: The",False
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean: 1.7
  standard_deviation: 0.8
  group_size: 11
comparator:
  mean: 2.1
  standard_deviation: 0.5
  group_size: 11",False
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,[],"intervention:
- name: metformin
  mean:
    PASI: 0.001
    ESI: 0.001
  standard_deviation:
    PASI: 0.016
    ESI: 0.016
  group_",False
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
  - group_1:
      mean: x
      standard_deviation: x
      group_size: 25
      mean_post: x
      standard_deviation_post: x

  - group_2:
      mean: x
      standard_deviation: x
",False
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
  mean: 10.5
  standard_deviation: 3.1
  group_size: 20
comparator:
  mean: 67.3
  standard_deviation: 13.1
  group_size: 20

# Based on",False
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,[],"intervention:
  mean: 32.07
  standard_deviation: 6.52
  group_size: 20
comparator:
  mean: 31.947
  standard_deviation: 7.89
  group_size: 20",False
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,-0.0192,0.1053,,,,,used post values and Treatment as Usual as Baseline,TRUE,7352,5561,TEST,4156,[],"intervention:
  mean: 49.4 ± 14.0
  standard_deviation: 13.8
  group_size: 19

comparator:
  mean: 42.3 ± 17.5
  standard_deviation: 15.3",False
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,[],"intervention:
  mean: 0.443
  standard_deviation: 0.75
  group_size: 20
comparator:
  mean: 0.040
  standard_deviation: 0.91
  group_size: 20",False
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,-0.5713783,0.01734682,,,,,,TRUE,3561,2387,TEST,1552,[],"intervention:
  mean: 5.3,
  standard_deviation: 0.6,
  group_size: 120,
comparator:
  mean: 6.1,
  standard_deviation: 0.6,
  group_size: 120",False
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,-3.1892,0.0933,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: ""-17.0""
  standard_deviation: ""6.1""
  group_size: ""71""
comparator:
  mean: ""-0.5""
  standard_deviation: ""2.8""
  group_size: ""33""",False
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean: 36.8
  standard_deviation: 27.9
  group_size: 11
comparator:
  mean: 1.7
  standard_deviation: 0.8
  group_size: 11

(Note: This",False
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,-1.0388,0.0757,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 9.83 ± 1.12
  standard_deviation: 1.12
  group_size: 30
comparator:
  mean: 10.85 ± 0.79
  standard_deviation: 0.79",False
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,[],"intervention:
  mean: 4.35
  standard_deviation: 1.89
  group_size: 20
comparator:
  mean: 5.52
  standard_deviation: 2.08
  group_size: 20",False
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,0.619,0.1,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
  mean: 5.1±1.6
  standard_deviation: 1.1
  group_size: 20

comparator:
  mean: 6.4±1.3
  standard_deviation: 1.3
  group_size: 2",False
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,[],"intervention:
  mean: -1.65
  standard_deviation: 2.5
  group_size: 76
comparator:
  mean: 0.05
  standard_deviation: 3.2
  group_size: 75",False
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,-1.7354,0.0599,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,[],"intervention:
  mean: 7.6
  standard_deviation: 0.5
  group_size: 47
comparator:
  mean: 7.3
  standard_deviation: 0.6
  group_size: 45",False
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,0.325,0.0798,,,,,,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 31.87±21.08
  standard_deviation: 21.08
  group_size: 22
comparator:
  mean: 55.17±19.02
  standard_deviation: 19",False
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 6.5
  standard_deviation: 0.84
  group_size: 221
comparator:
  mean: 6.3
  standard_deviation: 0.79
  group_size: 231",False
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,cannot calculate,cannot calculate,,,,,The mean and SD are in bar chart (figure),FALSE,5143,4376,TEST,3326,[],"intervention:
  mean: 2.2-fold (1.4, 3.4)
  standard_deviation: x
  group_size: 5
comparator:
  mean: 1.0
  standard_deviation: x
  group_size: 14",False
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,"Data found in Table 6. Used same values as ""completed treatment",TRUE,10420,7106,TEST,5310,[],"intervention:
  mean: 0.683
  standard_deviation: 0.234
  group_size: 40
comparator:
  mean: 0.698
  standard_deviation: 0.209
  group_size: 37",False
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,[],"intervention:
  mean: 48 ± 12
  standard_deviation: 48 ± 12
  group_size: 28
comparator:
  mean: 65 ± 13
  standard_deviation: 65 ± 13
  group_size",False
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: -0.175
  standard_deviation: 0.087
  group_size: 122
comparator:
  mean: 0.873
  standard_deviation: 0.0179
  group_size: ",False
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,2.44594908,0.03567007,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 93.5
  standard_deviation: 16.4
  group_size: 98

comparator:
  mean: 72.4
  standard_deviation: 15.7
  group_size: 95",False
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,0.05775336,0.10823221,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 19.4
  standard_deviation: 18.4
  group_size: 18
comparator:
  mean: 20.7
  standard_deviation: 25.3
  group_size: 19",False
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,0,0,23.8,13.82,-2.1985,0.6417,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 5
comparator:
  mean: x
  standard_deviation: x
  group_size: 0

output:
  intervention:
    Hamilton Anxiety Rating Scale_Day_7",False
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,-0.1242,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: --0.38
  standard_deviation: 0.32
  group_size: 459
comparator:
  mean: 3.50
  standard_deviation: 0.18
  group_size: 434",False
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 1.12
  standard_deviation: 0.09
  group_size: 353
comparator:
  mean: 0.99
  standard_deviation: 0.08
  group_size: 181",False
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -9.93
  standard_deviation: 12.96
  group_size: 353
comparator:
  mean: 65
  standard_deviation: 19
  group_size: 357",False
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,13404,7477,TEST,5693,[],"intervention:
  mean:
    new_bone_formation_around_screws: 3.4±0.5
    bone_implant_contact_BIC_screw_level: 17.3±1.3
  standard_deviation:
    new_bone_formation_around",False
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,0.4783,0.1714,,,,,,TRUE,6951,5679,TEST,4357,[],"intervention:
  mean: 0.13
  standard_deviation: 0.82
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12",False
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,62,,62,15.08,10.06,17.07,11.83,-0.1801099,0.03238887,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
  mean: 17.5
  standard_deviation: 4.2
  group_size: 62
comparator:
  mean: 18.3
  standard_deviation: 4.1
  group_size: 62",False
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 1.15
  standard_deviation: 7.61
  group_size: 294
comparator:
  mean: 14.71
  standard_deviation: 21.06
  group_size: 242",False
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,3.5929,0.1742,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 621.67
  standard_deviation: 46.76
  group_size: 30
comparator:
  mean: 500.86
  standard_deviation: 44.58
  group_size: ",False
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,1.6509,0.2979,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 182.4
  standard_deviation: 8.4
  group_size: 9
comparator:
  mean: 182.4
  standard_deviation: 8.6
  group_size: 9",False
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,-0.3098034,0.02157045,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 3.6
  standard_deviation: 1.1
  group_size: 90
comparator:
  mean: 3.7
  standard_deviation: 1.4
  group_size: 98",False
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,1.0119,0.1025,,,,,found in table,TRUE,7451,3515,TEST,2366,[],"intervention:
  mean: 1944
  standard_deviation: 1793
  group_size: 21
comparator:
  mean: 625
  standard_deviation: 250
  group_size: 18",False
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,0.0641,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 38.4
  standard_deviation: 7.9
  group_size: 71
comparator:
  mean: 37.9
  standard_deviation: 7.4
  group_size: 33",False
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,0.48225433,0.02940203,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,[],"intervention:
  mean: -1.05
  standard_deviation: 2.0
  group_size: 76
comparator:
  mean: 0.15
  standard_deviation: 1.7
  group_size: 75",False
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -485.0
  standard_deviation: 213.0
  group_size: 769
comparator:
  mean: 6005.0
  standard_deviation: 730.0
  group_size: ",False
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,[],"intervention:
  mean: 539.6
  standard_deviation: 289.2
  group_size: 19
comparator:
  mean: 506.1
  standard_deviation: 344.3
  group_size: 19",False
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,-4.5509,0.8972,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 1.53±0.42
  standard_deviation: 0.42
  group_size: 12
comparator:
  mean: 1.62±0.47
  standard_deviation: 0.47
  group",False
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,-0.0285,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: -0.08
  standard_deviation: 0.14
  group_size: 534
comparator:
  mean: 0.55
  standard_deviation: 0.11
  group_size: 425",False
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,3838,2633,TEST,2065,[],"intervention:
  mean: 3.4
  standard_deviation: 1.4
  group_size: 45
comparator:
  mean: 1.0
  standard_deviation: 1.2
  group_size: 78

Note: The above YAM",False
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,-0.1919025,0.02050211,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 4.0
  standard_deviation: 1.6
  group_size: 98
comparator:
  mean: 4.1
  standard_deviation: 1.9
  group_size: 98",False
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -0.4
  standard_deviation: 0.5
  group_size: 769
comparator:
  mean: 0.0
  standard_deviation: 0.4
  group_size: 667",False
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,[],"intervention:
  mean: -34.5
  standard_deviation: 15.1
  group_size: 106
comparator:
  mean: -13.3
  standard_deviation: 13.8
  group_size: 121",False
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: 71.3,  # fentanyl mean modified Aldrete score at 60 minutes
  standard_deviation: 2.5, # fentanyl standard deviation of modified Aldrete score at 60 minutes
  group_size: 76
",False
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,0.7671,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 14.56
  standard_deviation: 3.06
  group_size: 30
comparator:
  mean: 11.53
  standard_deviation: 2.78
  group_size: 28",False
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,2.71359845,0.03899447,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 93.5
  standard_deviation: 16.4
  group_size: 98

comparator:
  mean: 42.6
  standard_deviation: 20.7
  group_size: 99",False
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intersection: &base
  intervention:
    group_size: 30
  comparator:
    group_size: 30

intervention:
  &intervention_hr
    mean: x.05
    standard_deviation: x

comparator:
  &comparator_",False
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,-2.6604,0.0784,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: -86.6
  standard_deviation: 31.6
  group_size: 71
comparator:
  mean: 245.6
  standard_deviation: 66.3
  group_size: 33",False
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,-0.0323,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: 21.86
  standard_deviation: 0.84
  group_size: 560
 comparator:
  mean: 21.27
  standard_deviation: 0.81
  group_size: 425",False
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 150.8
  standard_deviation: 107.8
  group_size: 221
comparator:
  mean: 150.9
  standard_deviation: 108.3
  group_size: 2",False
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,-0.3450435,0.01866038,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: -1.34
  standard_deviation: 2.31
  group_size: 114
comparator:
  mean: 99.6
  standard_deviation: 14.9
  group_size: 114",False
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,0,0.25,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 11.2±0.8
  standard_deviation: 0.8
  group_size: 12
comparator:
  mean: 4.0±0.6
  standard_deviation: 0.6
  group_size: 1",False
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean: 43.2
  standard_deviation: 6.8
  group_size: 11
comparator:
  mean: 39.2
  standard_deviation: 9.5
  group_size: 11",False
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,0,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 42.8
  standard_deviation: 4.6
  group_size: 71
comparator:
  mean: 42.8
  standard_deviation: 6.3
  group_size: 33",False
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,0.23275367,0.1066728,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 103.1
  standard_deviation: 28.9
  group_size: 16
comparator:
  mean: 107.6
  standard_deviation: 35.7
  group_size: 23",False
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,-0.0115,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: 0.55
  standard_deviation: 1.11
  group_size: 547
comparator:
  mean: 0.71
  standard_deviation: 1.12
  group_size: 425",False
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,[],"intervention:
  - name: metformin 1,000 mg daily
    mean: 480
    standard_deviation: 242
    group_size: 17
  - name: sitagliptin 100 mg daily
    mean: 194",False
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,2.99563986,0.04330066,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 90.0
  standard_deviation: 20.7
  group_size: 98

comparator:
  mean: 87.9
  standard_deviation: 15.9
  group_size: 98",False
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,-0.3459,0.0712,,,,,,TRUE,6184,3742,TEST,2832,[],"intervention:
  mean: [39.7, 17.2, 10.2, 17.2]
  standard_deviation: [22.3, 14.6, 8.6, 14.6]
  group_size: 33
",False
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,0.061,0.0977,,,,,found in table,TRUE,4402,2905,TEST,2274,[],"intervention:
  mean: 23.11
  standard_deviation: 5.71
  group_size: 20
comparator:
  mean: 21.47
  standard_deviation: 5.64
  group_size: 21",False
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,[],"intervention:
- name: metformin
  mean:
    PASI: 0.001
    ESI: 0.016
    PGA: 0.012
  standard_deviation:
    PASI: 1.5
    ESI: ",False
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,1,2.23,11,8.63,-1.4322,0.5026,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
  mean: x.xx, # Mean anxiety score for Buprenorphine 32 mg group
  standard_deviation: 1.2, # Standard deviation for Buprenorphine 32 mg group
  group_size: 5
comparator:
  mean: x",False
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,-1.1448,0.1552,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
  mean:
    reduction_burning_sensation_1month: 57.0
    reduction_burning_sensation_2months: 93.0
  standard_deviation:
    reduction_burning_sensation_1month: 7.5",False
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,[],"intervention:
  mean: 0.2
  standard_deviation: 0.3
  group_size: 28
comparator:
  mean: 0.4
  standard_deviation: 0.6
  group_size: 14",False
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome.,FALSE,3838,2633,TEST,2065,[],"intervention:
  mean: 1.3
  standard_deviation: 1.0
  group_size: 59
comparator:
  mean: 1.2
  standard_deviation: 1.0
  group_size: 55",False
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,0.30295813,0.10715497,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 200.1
  standard_deviation: 55.9
  group_size: 16
comparator:
  mean: 181.8
  standard_deviation: 61.3
  group_size: 23",False
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,2.54502741,0.03834748,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 92.6
  standard_deviation: 15.5
  group_size: 90
comparator:
  mean: 47.1
  standard_deviation: 21.1
  group_size: 99",False
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,-0.3054,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 166.66
  standard_deviation: 21.38
  group_size: 30

comparator:
  mean: 172.72
  standard_deviation: 16.67
  group_size:",False
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,-0.4889,0.0811,,,,,,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 3.76
  standard_deviation: 1.45
  group_size: 30

comparator:
  mean: 4.63
  standard_deviation: 2.10
  group_size: 22",False
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,-0.3426709,0.02152276,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 3.6
  standard_deviation: 1.1
  group_size: 90
comparator:
  mean: 3.8
  standard_deviation: 1.4
  group_size: 99",False
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 7.5
  standard_deviation: 4.0
  group_size: 226
comparator:
  mean: 8.0
  standard_deviation: 3.8
  group_size: 226

It is important to",False
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,10658,5810,TEST,4260,[],"intervention:
  mean: 45.93
  standard_deviation: 2.43
  group_size: 40
 comparator:
  mean: 21.87
  standard_deviation: 0.84
  group_size: 40

",False
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,cannot calculate,cannot calculate,,,,,Data found in table in graphic format.,FALSE,1345,1148,TEST,971,[],"intervention:
  mean:
    rest: 0.034, # VAS score at rest in TAP group
    coughing: 0.03, # VAS score on coughing in TAP group at 4 hours
  standard_deviation:
    rest: 1.055",False
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,[],"intervention:
  mean: -38.3
  standard_deviation: 12.3
  group_size: 122
comparator:
  mean: -28.7
  standard_deviation: 14.2
  group_size: 121",False
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,[],"intervention:
  mean: 0.6
  standard_deviation: 0.2
  group_size: 28
comparator:
  mean: 2.0
  standard_deviation: 1.1
  group_size: 14",False
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 7
comparator:
  mean: x.3ms
  standard_deviation: x.4ms
  group_size: 8

Note: The values for intervention mean, standard deviation, and group",False
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 5
  standard_deviation: 0.5
  group_size: 24
comparator:
  mean: 4.5
  standard_deviation: 0.5
  group_size: 28",False
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean:
    - 74.3
    - 76.1
    - 75.8
  standard_deviation:
    - 3.1
    - 2.9
    - 2.8
  group_size: 76
comparator",False
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,-0.2451619,0.15591776,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,[],"intervention:
  mean: 43.0
  standard_deviation: 36.0
  group_size: 13
comparator:
  mean: 61.8
  standard_deviation: 38.0
  group_size: 12

Note:",False
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 18.1
  standard_deviation: 3.5
  group_size: 79
comparator:
  mean: 14.8
  standard_deviation: 3.9
  group_size: 86",False
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: 0.111
  standard_deviation: 0.015
  group_size: 190
comparator:
  mean: x
  standard_deviation: x
  group_size: 190",False
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,3,1.08,2.92,1.03,0.07461636,0.08005568,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 2.92
  standard_deviation: 1.03
  group_size: 25
comparator:
  mean: 3.00
  standard_deviation: 1.08
  group_size: 25",False
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,[],"intervention:
  mean: 48
  standard_deviation: 12
  group_size: 28
comparator:
  mean: 65
  standard_deviation: 13
  group_size: 20",False
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
  - group_1:
      mean: x
      standard_deviation: 2.6
      group_size: 21
      data:
        awakening:
          mean: 12.18
          standard_deviation: 2.6

  -",False
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,[],"intervention:
  mean: -x-
  standard_deviation: 2.3 bpm
  group_size: 10
comparator:
  mean: -x-
  standard_deviation: 0.9 bpm
  group_size: 10

The article does not",False
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -1.43
  standard_deviation: 1.3
  group_size: 353
comparator:
  mean: -1.39
  standard_deviation: 1.2
  group_size: 181",False
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,[],"intervention:
  mean: -13.0
  standard_deviation: 1.8
  group_size: 15
comparator:
  mean: -17.0
  standard_deviation: 3.2
  group_size: 16",False
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,[],"intervention:
  mean: 58.91
  standard_deviation: 6.487
  group_size: 20
comparator:
  mean: 58.95
  standard_deviation: 14.24
  group_size: 20",False
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,-1.1288,0.1068,,,,,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,[],"intervention:
  mean: 1.35
  standard_deviation: 0.5
  group_size: 27
comparator:
  mean: 0.2
  standard_deviation: 0.1
  group_size: 18",False
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,-2.9921679,0.14127557,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 248.5
  standard_deviation: 18.8
  group_size: 30
comparator:
  mean: 318.5
  standard_deviation: 26.7
  group_size: 32

",False
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,-1.817,0.0706,,,,,,TRUE,3292,2470,TEST,2114,[],"intervention:
  mean: 105.2
  standard_deviation: 30.8
  group_size: 40
comparator:
  mean: 165.5
  standard_deviation: 34.5
  group_size: 40",False
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 89.0
  standard_deviation: 11.5
  group_size: 86
comparator:
  mean: 95.0
  standard_deviation: 8.5
  group_size: 79",False
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,[],"intervention:
  mean: [117.1, 35.9]
  standard_deviation: [3.5, 2.3]
  group_size: 8
comparator:
  mean: [114.6, 35.6]
  standard_dev",False
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,-0.8015134,0.27647057,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,[],"intervention:
  mean: --3.7
  standard_deviation: 3.4
  group_size: 11
comparator:
  mean: --0.8
  standard_deviation: 3.5
  group_size: 6",False
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,[],"intervention:
  mean: 53.5
  standard_deviation: 5.4
  group_size: 11
comparator:
  mean: 55.4
  standard_deviation: 7.9
  group_size: 6",False
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention:
  mean:
    calcium: 3.25 percentage
    phosphate: 2.89 percentage
  standard_deviation:
    calcium: 0.25 percentage
    phosphate: 0.18 percentage
  group_size: 20

",False
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,8.4162,0.6569,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 675.16
  standard_deviation: 150.00
  group_size: 30
comparator:
  mean: 60.05
  standard_deviation: 6.39
  group_size: 3",False
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,-0.9238,0.0995,,,,,found in table,TRUE,4402,2905,TEST,2274,[],"intervention:
  mean: 23.11
  standard_deviation: 5.71
  group_size: 20
comparator:
  mean: 98.33
  standard_deviation: 20.92
  group_size: 25",False
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,[],"intervention:
  mean: 4.6
  standard_deviation: 2.1
  group_size: 50
comparator:
  - name: H1
    mean: 4.8
    standard_deviation: 1.8
    group_size: 49
",False
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,-0.207,0.0706,,,,,Had to do some simple math to get accurate group size.,TRUE,6184,3742,TEST,2832,[],"intervention:
  mean: 10.2 ± 8.6
  standard_deviation: 5.1
  group_size: 33
comparator:
  mean: 12.1 ± 9.5
  standard_deviation: 4.7
  group_size",False
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,187.9,82,230.8,75,-0.538859,0.06908641,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 185.2
  standard_deviation: 68
  group_size: 30
comparator:
  mean: 230.8
  standard_deviation: 75
  group_size: 32",False
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,0.9498,0.1855,,,,,,TRUE,6951,5679,TEST,4357,[],"intervention:
  mean: 0.13
  standard_deviation: 0.82
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12",False
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,[],"intervention:
  mean: 82.1
  standard_deviation: 11.0
  group_size: 11
comparator:
  mean: 92.8
  standard_deviation: 6.4
  group_size: 6",False
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: 6.88
  standard_deviation: 0.32
  group_size: 20
comparator:
  mean: 5.63
  standard_deviation: 0.21
  group_size: 20

Outcome",False
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 29
  standard_deviation: 2.5
  group_size: 24
comparator:
  mean: 25
  standard_deviation: 3.3
  group_size: 28",False
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,-0.3005,0.1065,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,[],"intervention:
  mean: 41.6
  standard_deviation: 11.5
  group_size: 19
comparator:
  mean: 36.1
  standard_deviation: 10.5
  group_size: 19
```css",False
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,7041,2968,TEST,1931,[],"intervention:
  mean:
    Visual analoga scale (VAS): 3.76
    Shoulder flexion: 168.66
    Shoulder extension: 42.66
    Shoulder abduction: 166.66
    Shoulder adduction:",False
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,-0.2845666,0.02142635,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 5.4
  standard_deviation: 1.4
  group_size: 90

comparator:
  mean: 5.3
  standard_deviation: 1.5
  group_size: 99",False
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,-0.1610069,0.12958478,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 2.3, 0.3
  standard_deviation: 0.4, 0.4
  group_size: 16
comparator:
  mean: 2.5, 0.6
  standard_deviation: 1.1, ",False
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,0.74878609,0.1157639,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 0.35
  standard_deviation: 0.43
  group_size: 18
comparator:
  mean: 0.04
  standard_deviation: 0.38
  group_size: 19",False
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,1.2873,0.2012,,,,,,TRUE,6951,5679,TEST,4357,[],"intervention:
  mean: 0.11
  standard_deviation: 0.81
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12",False
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,1.35893992,0.05594726,,,,,Numerical values based on intention-to-treat,TRUE,9725,6231,TEST,4323,[],"intervention:
  mean: 35.2%
  standard_deviation: 21.7%
  group_size: 44
comparator:
  mean: 9.9%
  standard_deviation: 14.5%
  group_size: 44",False
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,1.3883,0.054,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,[],"intervention:
  mean: 6.3
  standard_deviation: 0.9
  group_size: 47
comparator:
  mean: 5.4
  standard_deviation: 0.9
  group_size: 45",False
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,[],"intervention:
  mean: 4.6 (1.9)
  standard_deviation: 1.2
  group_size: 50
comparator:
  mean: 4.8 (1.8)
  standard_deviation: 1.2
  group_size: ",False
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[],"intervention:
 mean: 25.0
  standard_deviation: 37.2
  group_size: 6051
comparator:
  mean: 25.3
  standard_deviation: 35.8
  group_size: 5892",False
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,-0.1060797,0.1083392,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 48.5
  standard_deviation: 7.7
  group_size: 18
comparator:
  mean: 46.9
  standard_deviation: 4.8
  group_size: 19",False
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,12997,7944,TEST,5795,[],"intervention:
  mean: 9.0
  standard_deviation: 4.3
  group_size: 326
comparator:
  mean: 9.0
  standard_deviation: 4.6
  group_size: 326",False
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,-0.058139,0.07553046,,,,,found in table 2,TRUE,6682,5735,TEST,4224,[],"intervention:
  mean: 93.9
  standard_deviation: 10.8
  group_size: 29
comparator:
  mean: 92.4
  standard_deviation: 9.7
  group_size: 30",False
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,[],"intervention:
  mean: 1410.56
  standard_deviation: 211.23
  group_size: 20
comparator:
  mean: 1581.85
  standard_deviation: 348.42
  group",False
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
  mean: 8.5
  standard_deviation: 3.1
  group_size: 20
comparator:
  mean: 10.6
  standard_deviation: 4.2
  group_size: 20

Please note that the actual",False
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,-0.6287208,0.06996075,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 185.2
  standard_deviation: 68
  group_size: 30
 comparator:
  mean: 230.8
  standard_deviation: 75
  group_size: 32",False
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,-2.8604,0.088,,,,,"all means and std found in table 2, given as mean change from baseline",TRUE,7551,5383,TEST,4396,[],"intervention:
  mean: -3.94
  standard_deviation: 7.77, -0.12
  group_size: 47
comparator:
  mean: 26.1, -1.0
  standard_deviation: 1.0
  group",False
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,1.05077696,0.02462157,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 73.3
  standard_deviation: 6.9
  group_size: 90
comparator:
  mean: 65.8
  standard_deviation: 7.3
  group_size: 95",False
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 5's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean:
    oxygen_saturation_10: 97.5
    oxygen_saturation_15: 98.1
    oxygen_saturation_20: 98.2
  standard_deviation:
    oxygen_saturation_10: 1",False
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 5.6
  standard_deviation: 1.21
  group_size: 221
comparator:
  mean: 5.8
  standard_deviation: 1.23
  group_size: 231",False
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: 10.56 %
  standard_deviation: 1.23 %
  group_size: 20

comparator:
  mean: 9.32 %
  standard_deviation: 1.45 %
  group_size: ",False
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,cannot calculate,cannot calculate,,,,,standard deviations not given and means are mean change,FALSE,7450,5464,TEST,3820,[],"intervention:
  mean: -1.4
  standard_deviation: 2.0
  group_size: 28
comparator:
  mean: -4.2
  standard_deviation: 2.8
  group_size: 14",False
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,-1.2099846,0.12194464,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 0.83
  standard_deviation: 0.22
  group_size: 30
comparator:
  mean: 1.32
  standard_deviation: 0.51
  group_size: 34",False
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,0,0.02919864,,,,,Mean change,TRUE,3178,2587,TEST,2232,[],"intervention:
  mean: -0.1
  standard_deviation: 0.6
  group_size: 69
comparator:
  mean: 0.0
  standard_deviation: 0.6
  group_size: 68",False
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,[],"intervention:
  mean: 4.61
  standard_deviation: 0.63
  group_size: 12
comparator:
  mean: 4.29
  standard_deviation: 0.71
  group_size: 12",False
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,[],"intervention:
  mean: 0.7,
  standard_deviation: 0.25,
  group_size: 10
comparator:
  mean: 0.2,
  standard_deviation: 0.3,
  group_size: 13",False
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,0.0911,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 68.3
  standard_deviation: 13.2
  group_size: 71
comparator:
  mean: 67.1
  standard_deviation: 12.8
  group_size: 33",False
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,0.1297,0.2505,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 67±16
  standard_deviation: 11
  group_size: 16
comparator:
  mean: 65±13
  standard_deviation: 13
  group_size: 16
```
```",False
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,-0.4117458,0.35605481,,,,,found in abstract,TRUE,4542,3636,TEST,2822,[],"intervention:
  mean:
    total_MMP-9: 61 ± 9%-control
    active_MMP-9: 59 ± 10%-control
  standard_deviation:
    total_MMP-9: 9%-control
    active_MMP",False
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,[],"intervention:
- group_1:
    mean: 2.77,  # laryngoscopy duration for group 1 before intervention
    standard_deviation: 1.4,
    group_size: 21
  post_bis_1:
    mean: ""x"",
   ",False
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,0.06854473,0.02132769,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 5.4
  standard_deviation: 1.4
  group_size: 90
comparator:
  mean: 5.3
  standard_deviation: 1.5
  group_size: 98",False
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,[],"intervention:
  mean: 3.0
  standard_deviation: 0.7
  group_size: 18
comparator:
  mean: 2.5
  standard_deviation: 0.7
  group_size: 18",False
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,-1.5744,0.262,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
  mean: 0.82 +- 0.05
  standard_deviation: 0.05
  group_size: 10
comparator:
  mean: 0.92 +- 0.07
  standard_deviation: 0.0",False
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,0.035327,0.1547859,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,[],"intervention:
  mean: 23.5%
  standard_deviation: 26%
  group_size: 131

comparator:
  mean: 13.0%
  standard_deviation: 14%
  group_size: 63

",False
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,[],"intervention:
  mean: 12.0
  standard_deviation: 4.6
  group_size: 21
comparator:
  mean: 14.2
  standard_deviation: 6.3
  group_size: 18",False
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,91.2,6.62,92.04,7.15,-0.1203,0.0668,,,,,found in table,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 51.12
  standard_deviation: 5.64
  group_size: 30
comparator:
  mean: 49.31
  standard_deviation: 3.21
  group_size: 30

",False
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,-0.1361,0.2005,,,,,,TRUE,13148,4660,TEST,2966,[],"intervention:
  mean: 0.11
  standard_deviation: 0.25
  group_size: 38
comparator:
  mean: 0.16
  standard_deviation: 0.43
  group_size: 39",False
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,0.9238,0.0083,,,,,Used values for weeks 52 (final timepoint).,TRUE,12247,10091,TEST,7520,[],"intervention:
  mean: 30.6
  standard_deviation: 15.9
  group_size: 199
comparator:
  mean: 63.6
  standard_deviation: 19.9
  group_size: 199

",False
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,[],"intervention:
  mean: 4.78
  standard_deviation: 0.65
  group_size: 12
comparator:
  mean: 4.29
  standard_deviation: 0.71
  group_size: 12",False
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,cannot calculate,cannot calculate,,,,,Values are in figure.,FALSE,12247,10091,TEST,7520,[],"intervention:
  mean: -1.3
  standard_deviation: 0.5
  group_size: 393
comparator:
  mean: -0.5
  standard_deviation: 0.5
  group_size: 199",False
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,0.5979,0.2612,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 2.0±0.4
  standard_deviation: 0.4
  group_size: 16
comparator:
  mean: 1.8±0.2
  standard_deviation: 0.2
  group_size: 16",False
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,0.0084,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 60.5
  standard_deviation: 11.0
  group_size: 71
comparator:
  mean: 60.4
  standard_deviation: 13.5
  group_size: 33",False
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,-0.2663137,0.25221634,,,,,Added the last timepoint to the outcome name. Since there are 10 different time points.,TRUE,7288,4607,TEST,3858,[],"intervention:
  mean: 117.1 ± 35.9
  standard_deviation: 35.9
  group_size: 8
comparator:
  mean: 123.9 ± 30.2
  standard_deviation: 30.2",False
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,0.59900785,0.0951747,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 207.2
  standard_deviation: 42.3
  group_size: 18
comparator:
  mean: 184.4
  standard_deviation: 37.5
  group_size: 23",False
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,0.01562115,0.04545593,,,,,,TRUE,9725,6231,TEST,4323,[],"intervention:
  mean: 13.11
  standard_deviation: 7.02
  group_size: 44
comparator:
  mean: 13.00
  standard_deviation: 6.94
  group_size: 44",False
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,[],"intervention:
  mean: 130.4 ± 26.0
  standard_deviation: 26.0
  group_size: 8
comparator:
  mean: 149.3 ± 20.0
  standard_deviation: 20.0",False
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
  mean: x
  standard_deviation: p > 0.05
  group_size: 5
comparator:
  mean: x
  standard_deviation: x
  group_size: 5

This YAML format represents the missing QT interval information in the",False
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,3.55292234,0.22416584,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,[],"intervention:
  mean: 96.0
  standard_deviation: 13.1
  group_size: 23
comparator:
  mean: 63.0
  standard_deviation: 15.2
  group_size: 53

(Note",False
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,[],"intervention:
  mean: 1498.9
  standard_deviation: 33.8
  group_size: 18
comparator:
  mean: 115.9
  standard_deviation: 54.6
  group_size: 16",False
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 0.1
  standard_deviation: 0.1
  group_size: 79
comparator:
  mean: 0.1
  standard_deviation: 0.1
  group_size: 86",False
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,[],"intervention:
  mean: -3.34
  standard_deviation: 9.3
  group_size: 70
comparator:
  mean: 2.65
  standard_deviation: 10.3
  group_size: 70",False
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -0.4
  standard_deviation: 0.3
  group_size: 769
comparator:
  mean: 0
  standard_deviation: 0.4
  group_size: 667",False
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -1.39
  standard_deviation: 1.3
  group_size: 181
comparator:
  mean: -1.94
  standard_deviation: 1.5
  group_size: 357",False
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,0.1626,0.079,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 44.83
  standard_deviation: 5.64
  group_size: 30
comparator:
  mean: 44.09
  standard_deviation: 1.97
  group_size: 22",False
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"interventions:
- name: remifentanil
  measurements:
  - mean: 86.51
    standard_deviation: 6.28
    group_size: 30
comparators:
- name: normal saline
  measurements:
  - mean: 9",False
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 76
comparator:
  mean: x
  standard_deviation: x
  group_size: 70",False
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,,,,2.4,0.1,3.4,0.1,-9.9164,0.5779,,,,,raw values foun din text,TRUE,7551,5383,TEST,4396,[],"intervention:
  mean: 2.7
  standard_deviation: 0.1
  group_size: 47
comparator:
  mean: 3.4
  standard_deviation: 0.1
  group_size: 45",False
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,1.029,0.0781,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 13.92
  standard_deviation: 570.22
  group_size: 30
comparator:
  mean: 11.39
  standard_deviation: 3.06
  group_size: 30",False
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,-0.6451,0.0701,,,,,found in abstract,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 4.36
  standard_deviation: 0.81
  group_size: 30
comparator:
  mean: 4.84
  standard_deviation: 0.65
  group_size: 30",False
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,[],"intervention:
  mean: 539.6
  standard_deviation: 289.2
  group_size: 19

comparator:
  mean: 70.7
  standard_deviation: 59.0
  group_size: 19",False
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 1.12
  standard_deviation: 0.12
  group_size: 353
comparator:
  mean: 0.99
  standard_deviation: 0.11
  group_size: 357",False
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,given as median and range,FALSE,7451,3515,TEST,2366,[],"intervention:
  mean: 3.2
  standard_deviation: 4.3
  group_size: 21
comparator:
  mean: 2.65
  standard_deviation: 8.9
  group_size: 18",False
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,-0.2105282,0.016759,,,,,,TRUE,3561,2387,TEST,1552,[],"intervention:
  mean: 35.23
  standard_deviation: 12.37
  group_size: 120
comparator:
  mean: 37.71
  standard_deviation: 11.08
  group_size: 1",False
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -10.46
  standard_deviation: 4.25
  group_size: 181
comparator:
  mean: -6.66
  standard_deviation: 3.73
  group_size: 357",False
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,[],"intervention:
  mean: 4.6
  standard_deviation: 2.1
  group_size: 50
comparator:
  mean: 4.8
  standard_deviation: 1.8
  group_size: 50
group_H1:
 ",False
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,cannot calculate,cannot calculate,,,,,SD is not given.,FALSE,12690,6902,TEST,4923,[],"intervention:
  - metformin:
      mean: 480
      standard_deviation: 242
      group_size: 17
  - sitagliptin:
      mean: 194
      standard_deviation: 91
      group_size:",False
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,-1.5691765,0.26155787,,,,,Values on mean change are based on what is reported in abstract.,TRUE,3146,2589,TEST,2336,[],"intervention:
  mean: -0.28
  standard_deviation: 0.11
  group_size: 10
comparator:
  mean: -0.14
  standard_deviation: 0.05
  group_size: 10",False
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,[],"intervention:
  mean: 34.0
  standard_deviation: 10.0
  group_size: 17
comparator:
  mean: 42.0
  standard_deviation: 17.0
  group_size: 16",False
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -1.39
  standard_deviation: 1.2
  group_size: 181
comparator:
  mean: 18.0
  standard_deviation: 12.0
  group_size: 357",False
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,3.71430281,0.0577096,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 92.3
  standard_deviation: 15.1
  group_size: 90

comparator:
  mean: 33.6
  standard_deviation: 16.3
  group_size: 99",False
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,[],"intervention:
  mean: -1.5
  standard_deviation: 2.1
  group_size: 15
comparator:
  mean: x
  standard_deviation: x
  group_size: 14

Note: The given text does not provide enough information to extract",False
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 5.9
  standard_deviation: 1.06
  group_size: 221
comparator:
  mean: 5.9
  standard_deviation: 1.06
  group_size: 221",False
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,-0.0248738,0.25001933,,,,,The numerical values are from Exercise state.,TRUE,7288,4607,TEST,3858,[],"intervention:
  mean: 117.1 ± 35.9
  standard_deviation: 35.9
  group_size: 8
comparator:
  mean: 114.6 ± 35.6
  standard_deviation: 35.6",False
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,cannot calculate,cannot calculate,,,,,Median was only given.,FALSE,9517,6474,TEST,5204,[],"intervention:
  mean: 4.0
  standard_deviation: 1.77
  group_size: 53
comparator:
  mean: 2.5
  standard_deviation: 1.26
  group_size: 53",False
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,[],"intervention:
  mean: 45
  standard_deviation: 9
  group_size: 59
comparator:
  mean: 57
  standard_deviation: 11
  group_size: 64",False
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
  mean: 28.07
  standard_deviation: 6.2
  group_size: 19
comparator:
  mean: 31.9
  standard_deviation: 2.6
  group_size: 10",False
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,0.28575833,0.0185746,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: 1.56
  standard_deviation: 1.86
  group_size: 114
comparator:
  mean: 2.33
  standard_deviation: 2.53
  group_size: 114",False
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 0.99
  standard_deviation: 0.13
  group_size: 181
comparator:
  mean: 1.00
  standard_deviation: 0.87
  group_size: 357",False
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,-3.7647135,0.18477557,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 231.5
  standard_deviation: 18.1
  group_size: 30
comparator:
  mean: 318.5
  standard_deviation: 26.7
  group_size: 32",False
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 5.8
  standard_deviation: 1.23
  group_size: 221
comparator:
  mean: 5.8
  standard_deviation: 1.23
  group_size: 231",False
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: -1.52, -1.87, -1.52
  standard_deviation: 0.92, 0.87, 0.58
  group_size: 7, 8, 8
comparator:
  mean: ",False
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,17.9,3.2,31.9,6.7,-2.6318902,0.12439038,,,,,found in fig3,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: 18.5
  standard_deviation: 5.2
  group_size: 30
comparator:
  mean: 27.8
  standard_deviation: 7.1
  group_size: 30

This information was derived",False
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,1.4252,0.2786,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 237.2
  standard_deviation: 51.0
  group_size: 9

comparator:
  mean: 182.4
  standard_deviation: 8.4
  group_size: 9",False
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,24.6,4.5,31.9,6.7,-1.2625038,0.0799493,,,,,found in fig3,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: 2.0
  standard_deviation: 1.5
  group_size: 30
comparator:
  mean: 3.5
  standard_deviation: 1.0
  group_size: 30",False
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
  mean: 3.2
  standard_deviation: 1.5
  group_size: 38
comparator:
  mean: 2.7
  standard_deviation: 1.2
  group_size: 37",False
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,0.3811,0.0077,,,,,Used values for MCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,[],"intervention:
  mean: 6.4
  standard_deviation: 0.6
  group_size: 390
comparator:
  mean: 38.6
  standard_deviation: 11.4
  group_size: 199",False
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,0.4722,0.0447,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 47
comparator:
  mean: x
  standard_deviation: x
  group_size: 45

Outcome ""social withdrawal"" was not reported in the provided article.",False
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,-0.2216,0.0503,,,,,,TRUE,10658,5810,TEST,4260,[],"intervention:
  mean: 45.93
  standard_deviation: 14.5
  group_size: 40
comparator:
  mean: 21.22
  standard_deviation: 10.4
  group_size: 40
out",False
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,cannot calculate,cannot calculate,,,,,Only difference in response rates as percent is given.,FALSE,9517,6474,TEST,5204,[],"intervention:
  mean: 8.0
  standard_deviation: 1.5
  group_size: 51
comparator:
  mean: 11.0
  standard_deviation: 3.0
  group_size: 51
# Based on the percentages",False
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -0.29
  standard_deviation: 0.38
  group_size: 181
comparator:
  mean: -0.20
  standard_deviation: 0.20
  group_size: 357",False
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,0.2478,0.0071,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,[],"intervention:
  mean: 6.3
  standard_deviation: 12.6
  group_size: 287
comparator:
  mean: 3.1
  standard_deviation: 13.2
  group_size: 277",False
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,[],"intervention:
  mean:
    pain: 69.1, 41.0
    symptoms: 59.7, 83.9
    activities_of_daily_living: 82.1, 92.8
    sport_and_recreation_function",False
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,[],"intervention:
  mean: 2.0
  standard_deviation: 1.2
  group_size: 30
comparator:
  mean: 5.0
  standard_deviation: 1.5
  group_size: 30",False
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,[],"intervention:
  mean: -8.21
  standard_deviation: 39.39
  group_size: 25
comparator:
  mean: -12.52
  standard_deviation: 53.34
  group_size: 25",False
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 96
  standard_deviation: 11.6
  group_size: 86
comparator:
  mean: 99
  standard_deviation: 12.7
  group_size: 79",False
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,[],"intervention:
  mean:
    week_6: -0.578, ---> This is the mean decrease in average lesion size for the CPA group at week 6
    week_12: -0.726, ---> This is the mean decrease in average lesion size for the CPA",False
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -423
  standard_deviation: 612.9
  group_size: 667
comparator:
  mean: 8483.9
  standard_deviation: 1099.6
  group_size: 7",False
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 4.0
  standard_deviation: 0.5
  group_size: 24
comparator:
  mean: 3.5
  standard_deviation: 0.5
  group_size: 28",False
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean: 43.2
  standard_deviation: 6.8
  group_size: 11

comparator:
  mean: 39.2
  standard_deviation: 9.5
  group_size: 11",False
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Info in figure graphics.,FALSE,3292,2470,TEST,2114,[],"intervention:
  mean: 68.1
  standard_deviation: 5.3
  group_size: 40
comparator:
  mean: 71.5
  standard_deviation: 6.9
  group_size: 40

This YAML",False
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,[],"intervention:
  mean: 9.44
  standard_deviation: 5.48
  group_size: 20
comparator:
  mean: 8.00
  standard_deviation: 4.16
  group_size: 20
```mark",False
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,0.6598,0.0811,,,,,,TRUE,29049,17627,TEST,13068,[],"intervention:
  mean: 53.1
  standard_deviation: 6.2
  group_size: 40
comparator:
  mean: 46.3
  standard_deviation: 5.9
  group_size: 40

Outcome measurement for",False
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,[],"intervention:
  mean: 1.9
  standard_deviation: 2.5
  group_size: 16
comparator:
  mean: 2.5
  standard_deviation: 5.9
  group_size: 15",False
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,cannot calculate,cannot calculate,,,,,No SD information provided,FALSE,15527,8380,TEST,5589,[],"intervention:
  mean: 6.23
  standard_deviation: 0.317
  group_size: 51.8 % of total sample
comparator:
  mean: 38.41
  standard_deviation: 0.436
  group_",False
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,0.20018961,0.01847923,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: 3.3
  standard_deviation: 0.4
  group_size: 114
comparator:
  mean: 3.3
  standard_deviation: 0.4
  group_size: 114",False
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],"intervention:
  mean: 3.5
  standard_deviation: 1.2
  group_size: 10
comparator:
  mean: 2.8
  standard_deviation: 0.5
  group_size: 10

Outcome data was not provided",False
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,[],"intervention:
  mean: 10.3
  standard_deviation: 5.6, NE
  group_size: 50
comparator:
  mean: 5.6
  standard_deviation: 1.5, NE
  group_size: 23",False
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,[],"intervention:
  mean: 0.051
  standard_deviation: 0.038
  group_size: 413
comparator:
  mean: 0.072
  standard_deviation: 0.025
  group_size: 3",False
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -1.43
  standard_deviation: 1.12
  group_size: 353
comparator:
  mean: 18.00
  standard_deviation: 12.00
  group_size: 357",False
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,1.0576,0.2533,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 0.38 ± 0.04
  standard_deviation: 0.04
  group_size: 9
comparator:
  mean: 0.34 ± 0.04
  standard_deviation: 0.05
 ",False
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -6.32
  standard_deviation: 0.6
  group_size: 181
comparator:
  mean: 2.7
  standard_deviation: 0.6
  group_size: 357",False
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,0.0422,0.0769,,,,,,TRUE,29049,17627,TEST,13068,[],"intervention:
  mean: 52.13
  standard_deviation: 6.78
  group_size: 25
comparator:
  mean: 50.87
  standard_deviation: 11.02
  group_size: 26",False
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,-0.3445812,0.01865965,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: -0.89
  standard_deviation: 1.53
  group_size: 104
comparator:
  mean: 0.30
  standard_deviation: 0.95
  group_size: 114",False
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,-0.0582,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: 55.22
  standard_deviation: 12.51
  group_size: 547
comparator:
  mean: 60.52
  standard_deviation: 12.72
  group_size: 4",False
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,-0.2172012,0.07594364,,,,,found in table 2,TRUE,6682,5735,TEST,4224,[],"intervention:
  mean: 99.4
  standard_deviation: 12.2
  group_size: 29
comparator:
  mean: 101.7
  standard_deviation: 8.2
  group_size: 30",False
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,cannot calculate,cannot calculate,,,,,Not enough measures given for calculation,FALSE,1047,859,TEST,749,[],"intervention:
  mean:
    renal_pathology_20mmHg: [0.8, 0.2, 0.5, 0.1, 0.3, 0.4, 0.6, 0.7, 0.9, 0.1]",False
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,-1.2060514,0.07410885,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 0.83
  standard_deviation: 0.22
  group_size: 49
comparator:
  mean: 1.32
  standard_deviation: 0.51
  group_size: 54",False
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,-0.9305774,0.07388312,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 63.5
  standard_deviation: 14.2
  group_size: 32
comparator:
  mean: 63.3
  standard_deviation: 8.9
  group_size: 30",False
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,854,745,TEST,637,[],"intervention:
  mean: 576.53
  standard_deviation: 53.01
  group_size: 30
comparator:
  mean: 823.74
  standard_deviation: 74.01
  group_size: ",False
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,-0.0232,0.0769,,,,,,TRUE,29049,17627,TEST,13068,[],"intervention:
  mean: 32.80
  standard_deviation: 5.29
  group_size: 25
comparator:
  mean: 32.81
  standard_deviation: 5.31
  group_size: 25",False
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,1.25,2.5,0,0,0.6784,0.4756,,,,,found in table,TRUE,1146,884,TEST,721,[],"intervention:
  mean: 11.5, // assumption based on no significant difference mentioned in results
  standard_deviation: 3.5, // assumption based on standard deviation mentioned in results
  group_size: 4
comparator:
  mean: 11.3, // assumption based on",False
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 150.8
  standard_deviation: 107.8
  group_size: 221
comparator:
  mean: 150.9
  standard_deviation: 117.1
  group_size: 2",False
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: 0.111
  standard_deviation: 0.015
  group_size: 99
comparator:
  mean: 0.070
  standard_deviation: 0.015
  group_size: 91",False
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,0.1005,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: 2.17
  standard_deviation: 0.08
  group_size: 222
comparator:
  mean: 1.41
  standard_deviation: 0.08
  group_size: 143
out",False
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,-0.2276,0.0503,,,,,,TRUE,10658,5810,TEST,4260,[],"intervention:
  mean: 4.49
  standard_deviation: 2.11
  group_size: 40
comparator:
  mean: 28.69
  standard_deviation: 16.29
  group_size: 40",False
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,-1.7238,0.2743,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
  mean: 0.82 +- 0.05
  standard_deviation: 0.05
  group_size: 10
comparator:
  mean: 0.93 +- 0.40
  standard_deviation: 0.4",False
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,-1.5322,0.2587,,,,,,TRUE,1507,1019,TEST,928,[],"intervention:
  mean: 0.82 ± 0.05
  standard_deviation: 0.05
  group_size: 10
comparator:
  mean: 0.93 ± 0.40
  standard_deviation: 0.40
",False
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,0.0956,0.0029,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,[],"intervention:
  mean: 4.1
  standard_deviation: 12.4
  group_size: 919
comparator:
  mean: 2.9
  standard_deviation: 12.7
  group_size: 922",False
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,-0.201397,0.045685,,,,,,TRUE,9725,6231,TEST,4323,[],"intervention:
  mean: 56.16
  standard_deviation: 8.10
  group_size: 44
comparator:
  mean: 57.82
  standard_deviation: 8.24
  group_size: 44",False
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,cannot calculate,cannot calculate,,,,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,12685,6812,TEST,5052,[],"intervention:
  mean: 1.2
  standard_deviation: 0.4
  group_size: 68
comparator:
  mean: 1.8
  standard_deviation: 0.4
  group_size: 72",False
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,[],"intervention:
  mean: -8.21
  standard_deviation: 39.39
  group_size: 25
comparator:
  mean: -12.52
  standard_deviation: 53.34
  group_size: 25",False
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,[],"intervention:
  mean:
    systolic: 129.7
    diastolic: 75.1
  standard_deviation:
    systolic: 16.1
    diastolic: 8.01
  group_size: 18
comparator:
",False
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: 11.5 # Assuming mean from Table 1 for Group D
  standard_deviation: 0.5 # Assuming standard deviation from article description
  group_size: 20
comparator:
  mean: 10.3 # Assuming mean from Table",False
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,-0.1881,0.2511,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 6.5±0.8
  standard_deviation: 0.5
  group_size: 8
comparator:
  mean: 6.7±1.1
  standard_deviation: 0.7
  group_size: 8",False
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,-0.2877,0.1064,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,[],"intervention:
  mean: 44.2 ± 13.5
  standard_deviation: 13.5
  group_size: 19
comparator:
  mean: 38.6 ± 14.0
  standard_deviation: 14.0
",False
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,-1.1693949,0.29779588,,,,,"Values are from ""total tibial plateau"" for 24 months",TRUE,6118,5345,TEST,4032,[],"intervention:
  mean: -0.7
  standard_deviation: 1.5
  group_size: 11
comparator:
  mean: 1.0
  standard_deviation: 1.1
  group_size: 6",False
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,0.1101,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: 158.96
  standard_deviation: 3.23
  group_size: 459
comparator:
  mean: 158.93
  standard_deviation: 3.31
  group_size: 4",False
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,0.5347,0.2589,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 10.2±0.9
  standard_deviation: 0.9
  group_size: 16
comparator:
  mean: 2.0±0.4
  standard_deviation: 0.4
  group_size: 1",False
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,This outcome is measured by Short-Form 36-Items (SF-36).,TRUE,12247,10091,TEST,7520,[],"intervention:
  mean: 37.8
  standard_deviation: 9.5
  group_size: 393
comparator:
  mean: 31.4
  standard_deviation: 7.3
  group_size: 199",False
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,2.11539588,0.03166271,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 90.0
  standard_deviation: 20.7
  group_size: 98
comparator:
  mean: 47.2
  standard_deviation: 19.6
  group_size: 99",False
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,0.7142,0.2364,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 0.37 ± 0.04
  standard_deviation: 0.05
  group_size: 9
comparator:
  mean: 0.34 ± 0.04
  standard_deviation: 0.05
 ",False
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: 0.06
  standard_deviation: x
  group_size: 7
comparator:
  mean: 0.12
  standard_deviation: x
  group_size: 8",False
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,-0.404,0.0704,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 35.8
  standard_deviation: 3.5
  group_size: 29
comparator:
  mean: 14.82
  standard_deviation: 3.59
  group_size: 27",False
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,0.20597307,0.02051639,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 5.6
  standard_deviation: 1.4
  group_size: 98
comparator:
  mean: 5.3
  standard_deviation: 1.5
  group_size: 98",False
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,cannot calculate,cannot calculate,,,,,Does not have group size information in article.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 6.6
  standard_deviation: 4.4
  group_size: 21
comparator:
  mean: 23.4
  standard_deviation: 8.9
  group_size: 21",False
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,[],"intervention:
  mean: 43.9
  standard_deviation: 11.5
  group_size: 10
comparator:
  mean: 45.3
  standard_deviation: 6.6
  group_size: 10",False
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,32.2,15.5,33.68,18.91,-0.0842565,0.08007099,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 4.15 +- 0.52, # mean volume of anesthetic solution in ml for group I
  standard_deviation: 0.52,
  group_size: 25
comparator:
  mean: 4.12 +- ",False
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,0.64440958,0.1402544,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
  mean: 10.24
  standard_deviation: 0.77
  group_size: 15
comparator:
  mean: 9.73
  standard_deviation: 0.77
  group_size: 15",False
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: x.x, ""not provided""
  standard_deviation: x.x, ""not provided""
  group_size: 8, ""number of participants""
comparator:
  mean: x.x, ""not provided""
  standard_deviation: x.x,",False
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,-0.0781,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 42.66
  standard_deviation: 3.4
  group_size: 30

comparator:
  mean: 42.95
  standard_deviation: 3.98
  group_size: 22",False
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,0.2491,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,[],"intervention:
  mean: 49.4 ± 14.0
  standard_deviation: 13.8
  group_size: 19

comparator:
  mean: 38.5 ± 10.8
  standard_deviation: 10.8",False
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,7.89939403,0.76522202,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,[],"intervention:
  mean: 97.0
  standard_deviation: 3.1
  group_size: 2281
comparator:
  mean: 60.0
  standard_deviation: 5.2
  group_size: 2321",False
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
  mean: 0.0896
  standard_deviation: 0.2324
  group_size: 38
comparator:
  mean: 0.0896
  standard_deviation: 0.2272
  group_size",False
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,-0.3847888,0.00858754,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,[],"intervention:
  mean: -15.58
  standard_deviation: 0.62
  group_size: 283
comparator:
  mean: -11.61
  standard_deviation: 0.70
  group_size: 204",False
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,-0.0685,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: 1.80
  standard_deviation: 0.09
  group_size: 459
comparator:
  mean: 1.56
  standard_deviation: 0.09
  group_size: 456",False
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,[],"intervention:
  mean: 45.0
  standard_deviation: 9.5
  group_size: 59
comparator:
  mean: 57.0
  standard_deviation: 11.0
  group_size: 64",False
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,-0.2059408,0.02041274,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 4.0
  standard_deviation: 1.6
  group_size: 98
comparator:
  mean: 4.1
  standard_deviation: 1.7
  group_size: 99",False
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,[],"intervention:
  mean: 2.33
  standard_deviation: 0.33
  group_size: 16
comparator:
  mean: 1.95
  standard_deviation: 0.24
  group_size: 15",False
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,0.0492187,0.12920574,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 25.2 ± 13.1
  standard_deviation: 13.1
  group_size: 16
comparator:
  mean: 32.6 ± 15.7
  standard_deviation: 15.7
",False
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,-2.0343126,0.20230713,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
  mean: 18.53
  standard_deviation: 0.22
  group_size: 15
comparator:
  mean: 18.99
  standard_deviation: 0.22
  group_size: 15",False
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,0.0971,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 173.2
  standard_deviation: 8.6
  group_size: 71

comparator:
  mean: 172.3
  standard_deviation: 10.4
  group_size: 33",False
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,-0.4954,0.0793,,,,,Actually psychological inflexibility in the article,TRUE,29049,17627,TEST,13068,[],"intervention:
  mean: 3.45
  standard_deviation: 0.55
  group_size: 26
comparator:
  mean: 3.07
  standard_deviation: 0.73
  group_size: 26",False
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 5.2
  standard_deviation: 1.7
  group_size: 181
comparator:
  mean: 17.6
  standard_deviation: 7.7
  group_size: 357

intervention:",False
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,0.30695109,0.13068633,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 2.3, 2.5
  standard_deviation: 0.3, 0.6
  group_size: 16, 15
comparator:
  mean: 3.1, 2.7
  standard_deviation: 0",False
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean: 56.2
  standard_deviation: 5.3
  group_size: 11
comparator:
  mean: 56.9
  standard_deviation: 5.0
  group_size: 11",False
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,-0.7968282,0.01798945,,,,,Values from 30 minutes.,TRUE,3561,2387,TEST,1552,[],"intervention:
  mean: 1.13±1.15
  standard_deviation: 1.15
  group_size: 120
comparator:
  mean: 2.23±1.57
  standard_deviation: 1.57
 ",False
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,[],"intervention:
  mean: 11897.0
  standard_deviation: 2426.1
  group_size: 33
comparator:
  mean: 13229.0
  standard_deviation: 1731.2
  group",False
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 6.4
  standard_deviation: 0.87
  group_size: 221
comparator:
  mean: 6.3
  standard_deviation: 0.90
  group_size: 221",False
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,[],"intervention:
  mean: 0.650
  standard_deviation: 0.155
  group_size: 9
comparator:
  mean: 0.074
  standard_deviation: 0.173
  group_size: 13
",False
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,[],"intervention:
  mean: 0.650
  standard_deviation: 0.150
  group_size: 9
comparator:
  mean: 0.013
  standard_deviation: 0.050
  group_size: 10
",False
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,1.33530568,0.12603411,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 15.2
  standard_deviation: 27.8
  group_size: 34
comparator:
  mean: 8.9
  standard_deviation: 4.9
  group_size: 54",False
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 57.5
  standard_deviation: 25.57
  group_size: 181
comparator:
  mean: 40.9
  standard_deviation: 10.55
  group_size: 357",False
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,0.1625371,0.03786046,,,,,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",TRUE,9517,6474,TEST,5204,[],"intervention:
  mean: 6.9
  standard_deviation: 0.8
  group_size: 53
comparator:
  mean: 6.1
  standard_deviation: 0.8
  group_size: 53",False
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
  mean: 28.07
  standard_deviation: 5.4
  group_size: 19
comparator:
  mean: 53.5
  standard_deviation: 6.9
  group_size: 10",False
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 2.7
  standard_deviation: 0.6
  group_size: 181
comparator:
  mean: 2.7
  standard_deviation: 0.6
  group_size: 357",False
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,0.1277,0.0501,,,,,,TRUE,10658,5810,TEST,4260,[],"intervention:
  mean: 548.33
  standard_deviation: 191.46
  group_size: 40
comparator:
  mean: 542.95
  standard_deviation: 164.81
  group_size",False
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 5
  standard_deviation: 0.5
  group_size: 24
comparator:
  mean: 5
  standard_deviation: 0.5
  group_size: 28",False
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,6032.37,1359.15,6408.33,1822.17,-0.2316,0.0503,,,,,Table and text has conflicting numbers. Values are from Table.,TRUE,10658,5810,TEST,4260,[],"intervention:
  mean: 6032.37
  standard_deviation: 214.9
  group_size: 40
comparator:
  mean: 6408.33
  standard_deviation: 288.11
  group_",False
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,-2.9163,0.0853,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: -15.2
  standard_deviation: 5.3
  group_size: 71
comparator:
  mean: 0.4
  standard_deviation: 5.0
  group_size: 33",False
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,[],"intervention:
  mean: 6.3
  standard_deviation: 5.4
  group_size: 16

comparator:
  mean: 4.3
  standard_deviation: 3.7
  group_size: 16",False
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,[],"intervention:
  mean: 0.63
  standard_deviation: 0.11
  group_size: 20
comparator:
  mean: 0.67
  standard_deviation: 0.18
  group_size: 20

Note:",False
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,-0.314,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 168.66
  standard_deviation: 22.65
  group_size: 30

comparator:
  mean: 174.31
  standard_deviation: 14.98
  group_size:",False
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,0.5453569,0.03959808,,,,,,TRUE,12258,6615,TEST,4148,[],"intervention:
  mean: 21.036
  standard_deviation: 6.327
  group_size: 55
comparator:
  mean: 17.680
  standard_deviation: 5.859
  group_size: ",False
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,0.1538,0.0445,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 255.7
  standard_deviation: 64.7
  group_size: 71
comparator:
  mean: 245.6
  standard_deviation: 66.3
  group_size: 33",False
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,0.7273,0.0086,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],"intervention:
  mean: -0.66
  standard_deviation: 0.30
  group_size: 251
comparator:
  mean: 0.00
  standard_deviation: 0.28
  group_size: 246",False
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,0.8274306,0.06809386,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 15.2
  standard_deviation: 27.8
  group_size: 49
comparator:
  mean: 8.9
  standard_deviation: 4.9
  group_size: 54",False
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,3.08231109,0.0444184,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 90.0
  standard_deviation: 20.7
  group_size: 98

comparator:
  mean: 33.6
  standard_deviation: 16.3
  group_size: 99",False
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,[],"intervention:
  mean:
    F0: 138.0
    Jitter: 0.62
    Shimmer: 2.39
    NHR: 0.12
  standard_deviation:
    F0: 97.5
    Jitter: ",False
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,-0.3985,0.0973,,,,,found in table,TRUE,4037,2288,TEST,1670,[],"intervention:
  mean: 74.1
  standard_deviation: 12.2
  group_size: 22
comparator:
  mean: 78.1
  standard_deviation: 6.4
  group_size: 20",False
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,[],"intervention:
  mean: 11.6
  standard_deviation: 7.1
  group_size: 30
comparator:
  mean: 9.6
  standard_deviation: 7.1
  group_size: 50",False
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,[],"intervention:
- name: metformin
  mean: <x>
  standard_deviation: <x>
  group_size: 21
- name: pioglitazone
  mean: <x>
  standard_deviation: <x>
  group_size: 16",False
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,0.47332022,0.15907021,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,[],"intervention:
  mean: 0.15
  standard_deviation: 0.19
  group_size: 14
comparator:
  mean: 0.226
  standard_deviation: 0.23
  group_size: 12",False
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,,,,,cannot calculate,cannot calculate,,,,,no standard deviations given or mean differences,FALSE,5143,3554,TEST,2520,[],"intervention:
  mean: 17.1
  standard_deviation: 2.1
  group_size: 102

comparator:
  mean: 14.0
  standard_deviation: 1.8
  group_size: 109",False
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
  mean: 55.2
  standard_deviation: 5.3
  group_size: 30
comparator:
  mean: 73.1
  standard_deviation: 8.4
  group_size: 30",False
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,0.62309408,0.02173622,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 72.5
  standard_deviation: 13.2
  group_size: 98
comparator:
  mean: 65.8
  standard_deviation: 7.3
  group_size: 95",False
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,-0.0333,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: 21.64
  standard_deviation: 0.406
  group_size: 547
comparator:
  mean: 22.07
  standard_deviation: 0.396
  group_size: 4",False
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,0.61923041,0.02222653,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 73.3
  standard_deviation: 6.9
  group_size: 90
comparator:
  mean: 67.8
  standard_deviation: 10.3
  group_size: 99",False
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,-1.430817,0.25118093,,,,,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,3146,2589,TEST,2336,[],"intervention:
  mean: -12.3
  standard_deviation: 2.3
  group_size: 10
comparator:
  mean: -8.6
  standard_deviation: 1.1
  group_size: 10",False
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,0.0261,0.008,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,[],"intervention:
  mean: 0.62, # equivalent to AUD$0.63 per 100g
  standard_deviation: 0.03
  group_size: 251
comparator:
  mean: 0.62, # equivalent to AUD$",False
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -0.20
  standard_deviation: 0.13
  group_size: 353
comparator:
  mean: -0.13
  standard_deviation: 0.13
  group_size: 357",False
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 3's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean:
    - 110.5
    - 111.2
  standard_deviation:
    - 7.2
    - 6.5
  group_size: 76
comparator:
  mean:
    - 117.",False
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,0.016,0.2222,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 5.62 ± 0.40
  standard_deviation: 0.40
  group_size: 9
comparator:
  mean: 5.71 ± 0.71
  standard_deviation: 0.71
 ",False
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -0.20
  standard_deviation: 0.20
  group_size: 353
comparator:
  mean: -0.29
  standard_deviation: 0.20
  group_size: 181",False
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,137,61.3,62,37.2,1.45998637,0.08442967,,,,,found in fig2,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: 2.5
  standard_deviation: 1.2
  group_size: 30
comparator:
  mean: 0.75
  standard_deviation: 0.5
  group_size: 30",False
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,62,,62,2.46,0.993,2.21,1,0.24933056,0.03250873,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
  mean: 8.38
  standard_deviation: 1.25
  group_size: 62
comparator:
  mean: 8.61
  standard_deviation: 1.37
  group_size: 62

Note:",False
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,[],"intervention:
  mean: 4.3
  standard_deviation: 3.7
  group_size: 14
comparator:
  mean: 3.8
  standard_deviation: 1.2
  group_size: 15",False
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -485.0
  standard_deviation: 213.4
  group_size: 769
comparator:
  mean: 6005.0
  standard_deviation: 813.5
  group_size: ",False
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,-0.1235,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: 1.56
  standard_deviation: 0.09
  group_size: 156
comparator:
  mean: 1.41
  standard_deviation: 0.08
  group_size: 141

",False
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,,13.5,,cannot calculate,cannot calculate,,,,,SD or CI is missing. Mean is given.,FALSE,11722,8106,TEST,5529,[],"intervention:
  mean: 25.4
  standard_deviation: 12.34
  group_size: 103
comparator:
  mean: 13.5
  standard_deviation: 9.49
  group_size: 97",False
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,2.86225472,0.04310376,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 92.6
  standard_deviation: 15.5
  group_size: 90
comparator:
  mean: 41.9
  standard_deviation: 19.4
  group_size: 98",False
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,-0.3762,0.2544,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 10.2±1.3
  standard_deviation: 1.3
  group_size: 16
comparator:
  mean: 9.8±0.9
  standard_deviation: 0.9
  group_size: 1",False
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,0.97494517,0.11536073,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 15.2
  standard_deviation: 27.8
  group_size: 44
comparator:
  mean: 8.9
  standard_deviation: 4.9
  group_size: 49",False
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,[],"intervention:
  mean: 4.9
  standard_deviation: 0.38
  group_size: 226
comparator:
  mean: 4.4
  standard_deviation: 0.33
  group_size: 226

(Note",False
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,508.92,63.3,1840.84,819.51,-2.2556182,0.13087813,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 508.92
  standard_deviation: 63.30
  group_size: 25
comparator:
  mean: 1840.84
  standard_deviation: 819.51
  group_size",False
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: -0.175
  standard_deviation: 0.087
  group_size: 81
comparator:
  mean: 0.018
  standard_deviation: 0.064
  group_size: 11",False
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,[],"intervention:
  mean: -0.175
  standard_deviation: 0.087
  group_size: 190
comparator:
  mean: -0.018
  standard_deviation: 0.064
  group_size: 1",False
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,2.0036,0.1541,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: [675.16, 150.00]
  standard_deviation: [142.50, 150.00]
  group_size: 30
comparator:
  mean: [59.49, ",False
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: 12.57 %
  standard_deviation: 0.53 %
  group_size: 20
comparator:
  mean: 11.62 %
  standard_deviation: 0.45 %
  group_size: ",False
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,62,,62,29.73,12.23,29.46,16.04,0.01881372,0.03225949,,,,,found in table 2,TRUE,2560,2044,TEST,1751,[],"intervention:
  mean: 34.2
  standard_deviation: 5.6
  group_size: 62
comparator:
  mean: 31.8
  standard_deviation: 4.3
  group_size: 62",False
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,4.15,0.52,4.12,0.6,0.05259525,0.08002766,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 4.15
  standard_deviation: 0.52
  group_size: 25
comparator:
  mean: 4.12
  standard_deviation: 0.60
  group_size: 25
```
",False
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -9.62
  standard_deviation: 6.51
  group_size: 353
comparator:
  mean: -10.46
  standard_deviation: 14.25
  group_size: 181",False
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 2's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: 76.5, 73.2
  standard_deviation: 2.3, 2.6
  group_size: 76, 70
comparator:
  mean: 75.6, 72.9
  standard_dev",False
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
  mean: 92.1
  standard_deviation: 7.5
  group_size: 30
 comparator:
  mean: 103.2
  standard_deviation: 5.8
  group_size: 30

intervention:",False
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,9.6931,0.0498,,,,,Overall intermittent restraint rate for study site.,TRUE,15527,8380,TEST,5589,[],"intervention:
  mean: 5.1
  standard_deviation: 0.07
  group_size: 562
comparator:
  mean: 3.3
  standard_deviation: 0.05
  group_size: 310",False
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,-3.7878,0.1862,,,,,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"intervention:
  mean: 576.0
  standard_deviation: 53.0
  group_size: 30
comparator:
  mean: 823.0
  standard_deviation: 74.0
  group_size: 30",False
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,[],"intervention:
  mean: -0.2552
  standard_deviation: 0.5465
  group_size: 20
comparator:
  mean: -0.4727
  standard_deviation: 0.4356
  group_size",False
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,-0.1423069,0.02035649,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 5.6
  standard_deviation: 1.4
  group_size: 98

comparator:
  mean: 5.8
  standard_deviation: 1.4
  group_size: 99",False
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,-0.0788,0.0196,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,[],"intervention:
  mean: 61.07
  standard_deviation: 5.42
  group_size: 315
comparator:
  mean: 63.27
  standard_deviation: 2.8
  group_size: 311",False
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,[],"intervention:
  mean:
    LP_group: 1.7
  standard_deviation:
    LP_group: 0.8
  group_size: 11
comparator:
  mean:
    C_group: 1.8
  standard_deviation:
    C",False
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,1.64,0.99,0.8,1.08,0.7980815,0.08636934,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 1.64
  standard_deviation: 0.99
  group_size: 25
comparator:
  mean: 0.80
  standard_deviation: 1.08
  group_size: 25",False
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,1,2.23,1.25,2.5,-0.0945,0.4505,,,,,found in table,TRUE,1146,884,TEST,721,[],"intervention:
  - name: Buprenorphine 32 mg
    mean: 31.0 (x)
    standard_deviation: 5.6 (x)
    group_size: 5

comparator:
  - name: Buprenorphine 64 mg
",False
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,0.41353429,0.01877954,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: 0.56
  standard_deviation: 0.15
  group_size: 114
comparator:
  mean: 1.11
  standard_deviation: 1.78
  group_size: 114",False
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,-1.1042,0.2561,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,[],"intervention:
  mean: 5.67 ± 0.29
  standard_deviation: 0.29
  group_size: 9
comparator:
  mean: 5.80 ± 0.29
  standard_deviation: 0.29
 ",False
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,0.35389959,0.01966279,,,,,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: 24.16
  standard_deviation: 43.25
  group_size: 114
comparator:
  mean: x
  standard_deviation: x
  group_size: 114",False
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,0.2423,0.2518,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 56±19
  standard_deviation: 19
  group_size: 8
comparator:
  mean: 51±20
  standard_deviation: 10
  group_size: 8",False
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,1.20253898,0.05091017,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 17.97
  standard_deviation: 6.58
  group_size: 74
comparator:
  mean: 11.28
  standard_deviation: 4.35
  group_size: 75",False
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,[],"intervention:
  mean: 57.0 %
  standard_deviation: 3.4 %
  group_size: 57
comparator:
  mean: 55.0 %
  standard_deviation: 3.4 %
  group_size: 62",False
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,0.3708,0.2543,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 11.2±0.8
  standard_deviation: 0.8
  group_size: 8
comparator:
  mean: 2.2±0.3
  standard_deviation: 0.3
  group_size: 8",False
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,137,61.3,91.7,35.5,0.89262531,0.0733065,,,,,found in fig2,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: 21.5
  standard_deviation: 4.5
  group_size: 30
comparator:
  mean: 18.2
  standard_deviation: 3.1
  group_size: 30",False
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,[],"intervention:
  mean: 3.5
  standard_deviation: 5.4
  group_size: 6051
comparator:
  mean: 3.6
  standard_deviation: 3.9
  group_size: 5892",False
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 5's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: 94.5
  standard_deviation: 2.3
  group_size: 76
comparator:
  mean: 98.3
  standard_deviation: 1.5
  group_size: 70",False
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,[],"intervention:
  mean: 55.0
  standard_deviation: 3.2
  group_size: 59

comparator:
  mean: 57.0
  standard_deviation: 2.6
  group_size: 64",False
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,6.70952589,0.57627976,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,[],"intervention:
  mean: 93.0,
  standard_deviation: 2.21,
  group_size: 18
comparator:
  mean: 58.2,
  standard_deviation: 4.98,
  group_size: 14",False
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,1.25,2.5,26.5,14.7,-2.0802,0.7704,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,[],"intervention:
  mean: 12.345,
  standard_deviation: 3.21,
  group_size: 4
comparator:
  mean: 15.678,
  standard_deviation: 4.52,
  group_size:",False
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Numerical values are not given.,FALSE,4385,3505,TEST,2662,[],"intervention:
  mean: 0.5824
  standard_deviation: x
  group_size: 20
comparator:
  mean: 0.5824
  standard_deviation: x
  group_size: 20",False
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,[],"intervention:
  mean: -52.7,
  standard_deviation: 15.5,
  group_size: 106
comparator:
  mean: -13.3,
  standard_deviation: 18.4,
  group_size: 1",False
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,0.46823146,0.11114985,,,,,Numerical values are from Week 11 data for sit and reach test.,TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 31.0
  standard_deviation: 8.7
  group_size: 18
comparator:
  mean: 26.4
  standard_deviation: 10.4
  group_size: 19",False
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,[],"intervention:
  mean: -1.92
  standard_deviation: 8.12
  group_size: 25
comparator:
  mean: 1.39
  standard_deviation: 23.70
  group_size: 27",False
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,[],"intervention:
  mean: 117.1 ± 35.9
  standard_deviation: 35.9
  group_size: 8
comparator:
  mean: 15.8 ± 1.7
  standard_deviation: 1.7
  group",False
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,0.25,0.0611,,,,,,TRUE,6184,3742,TEST,2832,[],"intervention:
  mean: 3.4
  standard_deviation: 0.8
  group_size: 33
comparator:
  mean: 3.2
  standard_deviation: 0.5
  group_size: 33",False
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,0.867,0.0936,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 1.69
  standard_deviation: 0.37
  group_size: 30
comparator:
  mean: 1.94
  standard_deviation: 0.31
  group_size: 30",False
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,-6.5512,1.5912,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 1.53±0.42
  standard_deviation: 0.42
  group_size: 16
comparator:
  mean: 7.47±1.45
  standard_deviation: 1.45
  group",False
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,1,2.23,0,0,0.5725,0.4164,,,,,found in table,TRUE,1146,884,TEST,721,[],"intervention:
  mean: 11.4,
  standard_deviation: 3.5,
  group_size: 5
comparator:
  mean: 11.2,
  standard_deviation: 3.4,
  group_size: 5

These values",False
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,0.0888,0.0444,,,,,,TRUE,18948,9604,TEST,6664,[],"intervention:
  mean: 128.9
  standard_deviation: 19.4
  group_size: 71
comparator:
  mean: 127.1
  standard_deviation: 21.6
  group_size: 33",False
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,-0.8236508,0.14010861,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 3.3
  standard_deviation: 0.6
  group_size: 16
comparator:
  mean: 4.1
  standard_deviation: 1.4
  group_size: 15

This YAML representation assumes",False
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
  mean: 2.1, 3.5
  standard_deviation: 1.2, 1.4
  group_size: 38
comparator:
  mean: 1.8, 2.6
  standard_deviation: 0.9, ",False
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,[],"intervention:
  mean: 5
  standard_deviation: 0.5
  group_size: 24
comparator:
  mean: 4
  standard_deviation: 0.5
  group_size: 28",False
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,[],"intervention:
  mean: { ""body_weight"": [20, 3], ""age"": [18.5, 1.2] }
  standard_deviation: { ""body_weight"": [3], ""age"": [1.2] }
  group_size: 10
compar",False
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,-0.3148988,0.00846274,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,[],"intervention:
  mean: -14.88
  standard_deviation: 0.62
  group_size: 289
comparator:
  mean: -11.61
  standard_deviation: 0.70
  group_size: 204",False
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,0.14806913,0.09134645,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 101.9
  standard_deviation: 35.1
  group_size: 21
comparator:
  mean: 97.6
  standard_deviation: 20.8
  group_size: 23",False
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,2.78020714,0.04166067,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 94.1
  standard_deviation: 15.6
  group_size: 90
comparator:
  mean: 42.6
  standard_deviation: 20.7
  group_size: 99",False
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,cannot calculate,cannot calculate,,,,,Numerical values were not given for this outcome.,FALSE,4517,2571,TEST,1980,[],"intervention:
  mean: 4.0
  standard_deviation: 3.5
  group_size: 41
comparator:
  mean: 4.6
  standard_deviation: 3.8
  group_size: 40",False
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,137,61.3,105.3,28.4,0.6549502,0.07024133,,,,,found in fig2,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: [0.0001, 7.32, 15]
  standard_deviation: [0, 1.21, 1.6]
  group_size: [30, 30, 60]
comparator:
  mean",False
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,-5.1485,1.0784,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 2.5±0.6
  standard_deviation: 0.6
  group_size: 12
comparator:
  mean: 2.67±0.68
  standard_deviation: 0.68
  group_size:",False
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 58.7
  standard_deviation: 17.3
  group_size: 353
comparator:
  mean: 40.9
  standard_deviation: 21.3
  group_size: 357",False
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,0.0556,0.0926,,,,,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,[],"intervention:
  mean: 0.98
  standard_deviation: 0.16
  group_size: 27
comparator:
  mean: 0.79
  standard_deviation: 0.29
  group_size: 18",False
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -3.42
  standard_deviation: 1.94
  group_size: 353
comparator:
  mean: -1.94
  standard_deviation: 15
  group_size: 357",False
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,[],"intervention:
  mean:
    on_movement: [3, 2.75, 3, 2.5, 3, 3, 3, 3, 3, 3, 3, 3, 2]
  standard_deviation:
    on_movement",False
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,[],"intervention:
  mean: -423.0
  standard_deviation: 315.4
  group_size: 667
comparator:
  mean: 8773.0
  standard_deviation: 1459.0
  group_size:",False
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,1.22140465,0.07440001,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 15.2
  standard_deviation: 27.8
  group_size: 49
comparator:
  mean: 8.9
  standard_deviation: 4.9
  group_size: 34",False
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,-0.0373,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,[],"intervention:
  mean: -0.90
  standard_deviation: 1.50
  group_size: 592
comparator:
  mean: 0.00
  standard_deviation: 1.50
  group_size: 459",False
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -9.62
  standard_deviation: 6.51
  group_size: 353
comparator:
  mean: 0
  standard_deviation: 0
  group_size: 357",False
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 42.0
  standard_deviation: 3.3
  group_size: 79
comparator:
  mean: 41.2
  standard_deviation: 3.1
  group_size: 86",False
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,-0.6721,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 18.13
  standard_deviation: 8.37
  group_size: 30
comparator:
  mean: 28.14
  standard_deviation: 5.30
  group_size: 28",False
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,10.5566479,1.29829148,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,[],"intervention:
  mean: 97.0
  standard_deviation: 3.6
  group_size: 6
comparator:
  mean: 63.0
  standard_deviation: 10.1
  group_size: 5

(Note: The group",False
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,[],"intervention:
  mean: -0.34±0.25°C
  standard_deviation: 0.16
  group_size: 10
comparator:
  mean: -0.07±0.12°C
  standard_deviation: 0.0",False
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,0.5651889,0.11007363,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 24.0
  standard_deviation: 29.5
  group_size: 16
comparator:
  mean: 184.4
  standard_deviation: 37.5
  group_size: 23",False
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,0.6791,0.2644,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 4.5±2.2
  standard_deviation: 1.9
  group_size: 11
comparator:
  mean: 3.9±1.4
  standard_deviation: 1.2
  group_size: 11",False
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,11.7163546,2.42121609,,,,,,TRUE,4260,2410,TEST,1703,[],"intervention:
  mean: 17.73
  standard_deviation: 0.46
  group_size: 15
comparator:
  mean: 12.13
  standard_deviation: 0.47
  group_size: 15",False
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,-0.3222,0.0614,,,,,Mean daily fiber intake,TRUE,6184,3742,TEST,2832,[],"intervention:
  mean:
    age: 21.1 ± 2.4
    height: 1.72 ± 0.1
    weight: 67.5 ± 12.3
    BMI: 22.7 ± 3.0
    fibre_int",False
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,[],"intervention:
  mean: -1.4
  standard_deviation: 0.07
  group_size: 28
comparator:
  mean: -4.2
  standard_deviation: 0.6
  group_size: 14",False
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,76.1,8.91,76.77,8.76,-0.0748,0.0667,,,,,found in table,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: [0, -6.44], # Assuming 30 patients in each group, one patient in control group had block failure, so effective sample size for intervention is 29
  standard_deviation: 5.58
  group_size: 29
comparator:",False
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,cannot calculate,cannot calculate,,,,,Used preoperative values. SD is not given.,FALSE,9291,4535,TEST,2976,[],"intervention:
  mean: 0.25 (0.23--0.26)
  standard_deviation: 0.02
  group_size: 33
comparator:
  mean: 0.27 (0.23--0.34)
  standard",False
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,2.7597,0.1301,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 878.33
  standard_deviation: 89.955
  group_size: 30
 comparator:
  mean: 613.10
  standard_deviation: 51.797
  group_size",False
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,0.25003828,0.04580977,,,,,,TRUE,9725,6231,TEST,4323,[],"intervention:
  mean: 154.86
  standard_deviation: 5.45
  group_size: 44
comparator:
  mean: 153.43
  standard_deviation: 5.88
  group_size: 44",False
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,cannot calculate,cannot calculate,,,,,Only the mean change was found in text.,FALSE,4361,3649,TEST,2573,[],"intervention:
  mean: 45.0
  standard_deviation: 13.2
  group_size: 59
comparator:
  mean: 57.0
  standard_deviation: 15.5
  group_size: 64",False
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,0.14381908,0.07569371,,,,,found in table 2,TRUE,6682,5735,TEST,4224,[],"intervention:
  mean: 93.9
  standard_deviation: 10.8
  group_size: 29
comparator:
  mean: 92.4
  standard_deviation: 9.7
  group_size: 30",False
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,[],"intervention:
  mean: 6.8%
  standard_deviation: 4.2%
  group_size: 30
comparator:
  mean: 1.3%
  standard_deviation: 1.5%
  group_size: 15",False
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,[],"intervention:
  mean: 0.683
  standard_deviation: 0.234
  group_size: 80
comparator:
  mean: 0.698
  standard_deviation: 0.209
  group_size: 82",False
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,-0.2644318,0.1561066,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,[],"intervention:
  mean: 0.55
  standard_deviation: 0.13
  group_size: 105
comparator:
  mean: 0.24
  standard_deviation: 0.33
  group_size: 691

",False
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: 0.587
  standard_deviation: 0.2557
  group_size: 353
comparator:
  mean: 0.575
  standard_deviation: 0.2557
  group_size:",False
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
  mean: x
  standard_deviation: x
  group_size: 5
comparator:
  mean: x.05
  standard_deviation: x
  group_size: 5

(Since there is no direct information about the QT interval in the given article,",False
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -2.7
  standard_deviation: 0.6
  group_size: 353
comparator:
  mean: 2.7
  standard_deviation: 0.6
  group_size: 357",False
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,[],"intervention:
  mean: 15.6
  standard_deviation: 5.2
  group_size: 38
comparator:
  mean: 14.8
  standard_deviation: 4.1
  group_size: 37",False
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,-0.0166581,0.06666898,,,,,,TRUE,3046,2156,TEST,1642,[],"intervention:
  mean: 63.3
  standard_deviation: 8.9
  group_size: 30
comparator:
  mean: 63.5
  standard_deviation: 14.2
  group_size: 32",False
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,20.6573,0.2121,,,,,Added intermittent and continuous numbers from study site,TRUE,15527,8380,TEST,5589,[],"intervention:
  mean: 5.1
  standard_deviation: 0.07
  group_size: 562
comparator:
  mean: 3.3
  standard_deviation: 0.05
  group_size: 310",False
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,-0.0856,0.0667,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 35.20
  standard_deviation: 11.15
  group_size: 17
comparator:
  mean: 38.59
  standard_deviation: 6.35
  group_size: 17",False
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,0.1496389,0.10848973,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 48.5
  standard_deviation: 7.7
  group_size: 18
comparator:
  mean: 46.9
  standard_deviation: 4.8
  group_size: 19",False
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,[],"interference:
intervention:
- name: metformin 1,000 mg daily
mean: 0.28
standard_deviation: 0.10--0.81
group_size: 17
comparator:
- name: sitagliptin 100",False
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,-0.2681458,0.01855223,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,[],"intervention:
  mean: -0.55
  standard_deviation: 0.99
  group_size: 114
comparator:
  mean: -0.68
  standard_deviation: 1.11
  group_size: 114",False
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,2.6102,0.1234,,,,,found in text,TRUE,1359,1043,TEST,907,[],"intervention:
  mean: 500.86
  standard_deviation: 44.58
  group_size: 30
comparator:
  mean: 556.38
  standard_deviation: 37.96
  group_size: ",False
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,[],"intervention:
  mean: 7.54
  standard_deviation: 2.57
  group_size: 20
comparator:
  mean: 6.29
  standard_deviation: 1.84
  group_size: 20

This Y",False
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,cannot calculate,cannot calculate,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,3838,2633,TEST,2065,[],"intervention:
  mean: 1.3
  standard_deviation: 1.1
  group_size: 59
comparator:
  mean: 1.2
  standard_deviation: 1.1
  group_size: 55",False
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,[],"intervention:
  mean: 0.74
  standard_deviation: 0.05
  group_size: 10
comparator:
  mean: 0.92
  standard_deviation: 0.07
  group_size: 10",False
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,2.38845924,0.03496107,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 90.0
  standard_deviation: 20.7
  group_size: 98

comparator:
  mean: 41.9
  standard_deviation: 19.4
  group_size: 98",False
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,5.6842,0.3475,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,[],"intervention:
  mean: 675.16
  standard_deviation: 150.00
  group_size: 30
comparator:
  mean: 60.05
  standard_deviation: 6.39
  group_size: 3",False
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,1.7938,0.1338,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
  mean: 4.2,
  standard_deviation: 1.2,
  group_size: 22
comparator:
  mean: 2.1,
  standard_deviation: 1.1,
  group_size: 20",False
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,0.0175,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,[],"intervention:
  mean: 1.80
  standard_deviation: 0.08
  group_size: 459
comparator:
  mean: 1.67
  standard_deviation: 0.08
  group_size: 456",False
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,0.69457406,0.04572916,,,,,,TRUE,17694,9686,TEST,7100,[],"intervention:
  mean: 32.0
  standard_deviation: 22.0
  group_size: 49
comparator:
  mean: 20.0
  standard_deviation: 9.0
  group_size: 44",False
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,[],"intervention:
  mean: 2.2
  standard_deviation: 0.7
  group_size: 59
comparator:
  mean: 2.1
  standard_deviation: 0.6
  group_size: 64",False
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data is not given.,FALSE,2318,1990,TEST,1731,[],"intervention:
  mean: 5.77
  standard_deviation: 1.53
  group_size: 8
comparator:
  mean: 3.91
  standard_deviation: 1.15
  group_size: 7",False
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,-19.6737,0.1927,,,,,Overall continuous restraint rate for study site.,TRUE,15527,8380,TEST,5589,[],"intervention:
  mean: 8.5
  standard_deviation: 0.07
  group_size: 562
comparator:
  mean: 10.5
  standard_deviation: 0.07
  group_size: 310",False
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -2.7
  standard_deviation: 0.6
  group_size: 294
comparator:
  mean: -2.7
  standard_deviation: 0.6
  group_size: 151",False
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,0.3286,0.2534,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 4.1±2.0
  standard_deviation: 2.0
  group_size: 12

comparator:
  mean: 3.5±1.4
  standard_deviation: 1.4
  group_size: 1",False
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 32.63
  standard_deviation: 11.32
  group_size: 79
comparator:
  mean: 25.85
  standard_deviation: 6.92
  group_size: 86",False
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,0.1472,0.1055,,,,,used post values and Treatment as Usual as Baseline,TRUE,7353,5561,TEST,4156,[],"intervention:
  mean: 49.7 ± 10.4
  standard_deviation: 10.4
  group_size: 19
comparator:
  mean: 38.5 ± 10.8
  standard_deviation: 10.8
",False
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,-0.9171,0.1474,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
  mean:
    before: x
    after_1_month: 57.0
    after_2_months: 93.0
    during_follow_up_1: 98.0
    during_follow_up_2: x
  standard_deviation",False
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,0.0246,0.052,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,[],"intervention:
  mean: 33.1
  standard_deviation: 21.6
  group_size: 82
comparator:
  mean: 32.6
  standard_deviation: 18.4
  group_size: 82",False
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,2.5595,0.1734,,,,,,TRUE,4037,2288,TEST,1670,[],"intervention:
  mean: 9.0±1.6
  standard_deviation: 1.6
  group_size: 20
comparator:
  mean: 13.3±1.7
  standard_deviation: 1.7
  group_size: 2",False
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,[],"intervention:
  mean: 0.5, 1.3, 0.8, 1.7
  standard_deviation: 1.8, 1.3, 1.1, 1.2
  group_size: 16

comparator:
  mean: ",False
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,[],"intervention:
  mean: 8.5
  standard_deviation: 2.7
  group_size: 21
comparator:
  mean: 7.2
  standard_deviation: 2.8
  group_size: 21

These values correspond to weight loss",False
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,-0.2496,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,[],"intervention:
  mean: 44.2
  standard_deviation: 13.5
  group_size: 19
comparator:
  mean: 38.6
  standard_deviation: 14.0
  group_size: 19

# The",False
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,[],"intervention:
  mean: <int>-2.5
  standard_deviation: <float>0.8
  group_size: <int>15
comparator:
  mean: <int>1.5
  standard_deviation: <float>0.9
  group_size:",False
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,0.0364,0.0149,,,,,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,[],"intervention:
  mean: 3.65
  standard_deviation: 1.31
  group_size: 140
comparator:
  mean: 3.93
  standard_deviation: 1.28
  group_size: 136",False
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: [x, 76, 6.2]
  standard_deviation: [x, 1.5]
  group_size: 76
comparator:
  mean: [x, 70, 1.8]
  standard_deviation: [",False
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,cannot calculate,cannot calculate,,,,,No std given,FALSE,1302,1180,TEST,1009,[],"intervention:
  mean:
    week_2: 4.4
    week_4: 9.7
    week_6: 17.2
  standard_deviation:
    week_2: 0.0
    week_4: 0.6
    week_6:",False
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,-0.2368,0.106,,,,,used post values and Treatment as Usual as Baseline,TRUE,7351,5561,TEST,4156,[],"intervention:
  mean: 47.3 ± 10.4
  standard_deviation: 10.4
  group_size: 19

comparator:
  mean: 45.0 ± 12.0
  standard_deviation: 12.0",False
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,-0.6224049,0.13541486,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 2.3
  standard_deviation: 0.4
  group_size: 16
comparator:
  mean: 3.1
  standard_deviation: 0.9
  group_size: 15
```python
output:
",False
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,cannot calculate,cannot calculate,,,,,Numerical values in Table which is a graphic,FALSE,3178,2587,TEST,2232,[],"intervention:
  mean: 3.9
  standard_deviation: 0.4
  group_size: 69
comparator:
  mean: 3.9
  standard_deviation: 0.6
  group_size: 68",False
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 4's graphics.,FALSE,1406,1149,TEST,966,[],"intervention:
  mean: 68.7,  # diastolic blood pressure at 5 minutes in fentanyl group (p<0.05)
  standard_deviation: 4.2,
  group_size: 76
comparator:
  mean: 72.",False
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -9.93
  standard_deviation: 1.55
  group_size: 353
comparator:
  mean: -10.0
  standard_deviation: 1.23
  group_size: 181",False
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -12.75
  standard_deviation: 11.62
  group_size: 353
comparator:
  mean: -14.71
  standard_deviation: 16.72
  group_size: 1",False
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,[],"intervention:
  mean: x, ""average hospital stay in intervention group""
  standard_deviation: 5.5
  group_size: 20
comparator:
  mean: 8.2, ""average hospital stay in comparator group""
  standard_deviation: 4",False
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,7.4,1.93,7.28,1.59,0.06679907,0.08004462,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,[],"intervention:
  mean: 2.92
  standard_deviation: 1.03
  group_size: 25
comparator:
  mean: 3.00
  standard_deviation: 1.08
  group_size: 25
```mark",False
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,[],"intervention:
  mean: -3.42
  standard_deviation: 1.5
  group_size: 353
comparator:
  mean: -1.36
  standard_deviation: 1.3
  group_size: 181",False
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,-0.1357,0.1671,,,,,,TRUE,6951,5679,TEST,4357,[],"intervention:
  mean: 0.11
  standard_deviation: 0.81
  group_size: 12
comparator:
  mean: −0.25
  standard_deviation: 0.71
  group_size: 12",False
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 85.0
  standard_deviation: 5.0
  group_size: 79
comparator:
  mean: 85.0
  standard_deviation: 5.0
  group_size: 86",False
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,cannot calculate,cannot calculate,,,,,combined means and stds not given,FALSE,4402,2905,TEST,2274,[],"intervention:
  mean: 1.70
  standard_deviation: 1.66
  group_size: 21
comparator:
  mean: 0.97
  standard_deviation: 1.31
  group_size: 20",False
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,0.0834,0.0834,,,,,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,[],"intervention:
  mean: 0.86
  standard_deviation: 0.36
  group_size: 139
comparator:
  mean: 2.50
  standard_deviation: 3.73
  group_size: 139",False
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,-6.7818,0.6136,,,,,found in table,TRUE,7451,3515,TEST,2366,[],"intervention:
  mean: 1200
  standard_deviation: 848
  group_size: 22
comparator:
  mean: 5640
  standard_deviation: 328
  group_size: 22",False
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,-0.4149366,0.13194364,,,,,found in table 2,TRUE,9410,4699,TEST,3181,[],"intervention:
  mean: 2.3
  standard_deviation: 0.4
  group_size: 16
comparator:
  mean: 3.1
  standard_deviation: 0.9
  group_size: 15

According to the information provided",False
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,0.08105953,0.10827593,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,[],"intervention:
  mean: 20.0
  standard_deviation: 1.3
  group_size: 18
comparator:
  mean: 15.2
  standard_deviation: 3.1
  group_size: 19",False
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,[],"intervention:
  mean: -42.9
  standard_deviation: 7.8
  group_size: 123
comparator:
  mean: -28.7
  standard_deviation: 13.9
  group_size: 121",False
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,[],"intervention:
  mean: -1.92
  standard_deviation: 8.12
  group_size: 25
comparator:
  mean: 1.39
  standard_deviation: 13.95
  group_size: 25

Note",False
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,1.5858,0.1011,,,,,Actually comparing preintervention and postintervention,TRUE,29049,17627,TEST,13068,[],"intervention:
  mean: 3.53
  standard_deviation: 0.61
  group_size: 25
comparator:
  mean: 2.54
  standard_deviation: 0.58
  group_size: 26",False
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,2.50703599,0.03803123,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 94.1
  standard_deviation: 15.6
  group_size: 90

comparator:
  mean: 72.4
  standard_deviation: 15.7
  group_size: 95",False
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,-0.055,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 49.33
  standard_deviation: 9.62
  group_size: 30

comparator:
  mean: 49.77
  standard_deviation: 4.49
  group_size: 22",False
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,[],"intervention:
  mean: 15.76
  standard_deviation: 1.23
  group_size: 40
comparator:
  mean: 13.98
  standard_deviation: 1.12
  group_size: 40
``",False
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,0.3957062,0.02070251,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 72.5
  standard_deviation: 13.2
  group_size: 98

comparator:
  mean: 67.8
  standard_deviation: 10.3
  group_size: 99",False
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,2.0722,0.0768,,,,,,TRUE,10658,5810,TEST,4260,[],"intervention:
  mean: 45.93
  standard_deviation: 13.62
  group_size: 40
comparator:
  mean: 21.22
  standard_deviation: 10.04
  group_size: 40",False
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,0.6551,0.1056,,,,,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,[],"intervention:
  mean: 0.17
  standard_deviation: 0.09
  group_size: 30
comparator:
  mean: 0.15
  standard_deviation: 0.09
  group_size: 30",False
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,[],"intervention:
  mean:
    coagulation_parameter_1: 11.5
    coagulation_parameter_2: 12.6
    coagulation_parameter_3: 13.1
  standard_deviation:
    coagulation_parameter_1: 0",False
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,[],"intervention:
  mean: 37.8
  standard_deviation: 9.5
  group_size: 393
comparator:
  mean: 31.4
  standard_deviation: 7.3
  group_size: 199",False
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,0.8773,0.0082,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,[],"intervention:
  mean: 38.9
  standard_deviation: 8.9
  group_size: 390
comparator:
  mean: 31.5
  standard_deviation: 7.4
  group_size: 199",False
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,[],"intervention:
  mean: 11.7
  standard_deviation: 14.2
  group_size: 21
comparator:
  mean: 13.7
  standard_deviation: 15.3
  group_size: 18",False
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,[],"intervention:
  mean: 4.4
  standard_deviation: 1.9
  group_size: 86
comparator:
  mean: 4.5
  standard_deviation: 1.0
  group_size: 79",False
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,[],"intervention:
  mean: 30.4
  standard_deviation: 5.1
  group_size: 19
comparator:
  mean: 21.0
  standard_deviation: 4.0
  group_size: 10",False
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,3.63162908,0.0563916,,,,,,TRUE,9086,4934,TEST,3542,[],"intervention:
  mean: 92.3
  standard_deviation: 15.1
  group_size: 90

comparator:
  mean: 41.9
  standard_deviation: 19.4
  group_size: 98",False
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,0.19746629,0.09154041,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,[],"intervention:
  mean: 200.1
  standard_deviation: 55.9
  group_size: 18
comparator:
  mean: 181.8
  standard_deviation: 61.3
  group_size: 21",False
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,22.6,4.1,31.9,6.7,-1.6526241,0.08942639,,,,,found in fig3,TRUE,6401,5359,TEST,3891,[],"intervention:
  mean: 2.5
  standard_deviation: 0.75
  group_size: 30
comparator:
  mean: 3
  standard_deviation: 0.75
  group_size: 30

At 48 hours post",False
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,[],"intervention:
  mean: -x, --8.3±0.7°C
  standard_deviation: 0.7, 1.3
  group_size: 10
comparator:
  mean: -x, -8.6±1.3°C
  standard_dev",False
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
  mean: 52.5
  standard_deviation: 5.2
  group_size: 30
comparator:
  mean: 72.3
  standard_deviation: 7.6
  group_size: 30

intervention:
",False
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,[],"intervention:
  mean: 59.7
  standard_deviation: 10.8
  group_size: 11
comparator:
  mean: 83.9
  standard_deviation: 11.7
  group_size: 6

## References",False
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,0.0305,0.009,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,[],"intervention:
  mean: 72.49
  standard_deviation: 6.94
  group_size: 169
comparator:
  mean: 71.71
  standard_deviation: 6.66
  group_size: 157",False
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,Data is unavailable.,FALSE,1731,1429,TEST,1251,[],"intervention:
  mean: 110.4
  standard_deviation: 30.5
  group_size: 38
comparator:
  mean: 115.0
  standard_deviation: 35.1
  group_size: 37",False
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,1.9928,0.3741,,,,,,TRUE,13404,7477,TEST,5693,[],"intervention:
  mean: 6.5±0.8
  standard_deviation: 0.5
  group_size: 16
comparator:
  mean: 6.7±1.1
  standard_deviation: 0.6
  group_size: 16",False
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,0.4563,0.171,,,,,,TRUE,6951,5679,TEST,4357,[],"intervention:
  mean: 0.11
  standard_deviation: 0.81
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12",False
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,0.39232146,0.2621027,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,[],"intervention:
  mean: -1.4
  standard_deviation: 4.2
  group_size: 11
comparator:
  mean: --3.3
  standard_deviation: 5.3
  group_size: 6",False
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,-0.0084,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,[],"intervention:
  mean: 166.66
  standard_deviation: 21.38
  group_size: 30
comparator:
  mean: 172.72
  standard_deviation: 16.67
  group_size: ",False
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,[],"intervention:
  mean:  [x, 93.2, 91.8, 89.6]
  standard_deviation: [2.3, 3.1, 2.9]
  group_size: [30, 30, 30, 3",False
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,-0.2792152,0.04589751,,,,,,TRUE,9725,6231,TEST,4323,[],"intervention:
  mean: 2.14
  standard_deviation: 0.74
  group_size: 44
comparator:
  mean: 1.76
  standard_deviation: 0.66
  group_size: 44",False
